Medical Device Investing Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation
Medical Device Investing Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635
Medical Device Investing Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule Study
Homerun Resources Inc. Signs Binding LOI for the Acquisition of Additional Mineral Rights in the Santa Maria Eterna Silica Sand District
